Ligand for herpes simplex virus entry mediator and methods...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 31/713 (2006.01) A61K 35/76 (2006.01) A61K 38/00 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61P 3/10 (2006.01) A61P 19/02 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 37/02 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C07K 16/08 (2006.01) C07K 19/00 (2006.01) C12N 15/62 (2006.01)

Patent

CA 2406132

A novel polypeptide ligand, p30, or LIGHT, for herpes virus entry mediator, HVEM, is provided. p30 is useful for modulating immune responses and in inhibiting infection and/or subsequent proliferation by herpes virus. HVEM fusion proteins are also provided. Methods for treating subjects with lymphoid cell disorders, tumors, autoimmune diseases, inflammatory disorders of those having or suspected of having a herpes virus infection, utilizing p30 and the fusion proteins of the invention, are also provided.

La présente invention concerne un nouveau ligand polypeptidique, la p30, ou LIGHT, pour le médiateur d'entrée du virus herpès simplex (HVEM). La p30 est utilisable pour modifier les réponses immunitaires et inhiber l'infection et/ou la prolifération ultérieure par le virus herpès. L'invention concerne également des protéines hybrides HVEM. L'invention concerne en outre des procédés de traitement de sujets souffrant de troubles de cellules lymphoïdes, de tumeurs, de maladies auto-immunes, de troubles inflammatoires de ceux souffrant ou susceptibles de souffrir d'une infection du virus herpès, mettant en oeuvre la p30 et les protéines hybrides de l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ligand for herpes simplex virus entry mediator and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ligand for herpes simplex virus entry mediator and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligand for herpes simplex virus entry mediator and methods... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1624529

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.